| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Nov 24 | LPTX Leap Therapeutics | Common Stock | Acquire X | Yes | No | 2.82 | 2,136 | 6.02 k | 678,456 | |
| 13 Nov 24 | LPTX Leap Therapeutics | Warrant Common Stock, $0.001 par value per share | Dispose X | Yes | No | 2.82 | 2,136 | 6.02 k | 0 | |
| 2 Oct 24 | LPTX Leap Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.45 | 85,000 | 208.25 k | 85,000 |
| 29 Jan 24 | LPTX Leap Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.68 | 85,000 | 227.80 k | 85,000 |
| 26 Jan 24 | LPTX Leap Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,000 | 0.00 | 5,086 |
| 26 Jan 24 | LPTX Leap Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,000 | 0.00 | 0 |
| 31 Aug 23 | GYRE Gyre Therapeutics | Series Y Preferred Stock | Sale back to company | Dispose D | Yes | No | 0 | 24.215 | 0.00 | 0 |
| 31 Aug 23 | GYRE Gyre Therapeutics | Series Y Preferred Stock | Sale back to company | Dispose D | No | No | 0 | 24.573 | 0.00 | 0 |
